Been taking Jakafi 5mg daily. I have been instructed to take it every other day for a week, then stop. Can I just...

TL;DR

No — do not stop Jakafi abruptly; follow your doctor's tapering schedule exactly as prescribed, because stopping suddenly can cause a dangerous rebound effect in your blood counts.

---

KEY POINTS

• Jakafi (ruxolitinib) requires a gradual taper, not abrupt stopping — your doctor prescribed every-other-day dosing for a reason
• Stopping suddenly can cause "rebound" — a dangerous spike in blood counts and symptoms — this is a known risk with JAK inhibitors
• Your post-transplant status makes this especially important — with mixed donor chimerism and del(7q) relapse, your blood counts are already unstable
• The tapering schedule protects your bone marrow — it allows your body to adjust gradually rather than experiencing a sudden shock
• Contact your transplant team before making ANY changes — they need to know if you're having side effects or want to stop

---

NEXT STEP

Call your transplant oncologist TODAY and tell them you want to stop Jakafi — do NOT change your dosing schedule on your own, even if you feel better.

---

FULL ANSWER

I understand the impulse to stop a medication, especially if you're experiencing side effects or feel like it's not helping. However, stopping Jakafi (ruxolitinib) abruptly — or even skipping ahead in your taper — can be dangerous, and here's why.

Why You Can't Just Stop Jakafi Now

The "Rebound Effect" Risk

JAK inhibitors like Jakafi cause a well-documented rebound phenomenon when stopped abruptly. Here's what happens:

During treatment: Jakafi suppresses JAK signaling, which dampens your bone marrow's inflammatory response and reduces abnormal cell proliferation. Your body adapts to this suppression.

Upon abrupt stopping: Your body suddenly loses the JAK inhibition, and your bone marrow can experience a rapid, dangerous rebound characterized by:

• Sudden spike in white blood cells (WBC) — potentially to very high levels
• Rapid increase in blast cells — the immature cells that characterize MDS/leukemia
• Worsening of MDS symptoms — fatigue, infections, bleeding
• Potential acceleration toward acute myeloid leukemia (AML) — in some cases

This rebound can happen within days to weeks of stopping the medication.

Your Specific Situation Makes This Higher Risk

Your medical profile shows several factors that make abrupt stopping particularly risky:

1. Post-transplant relapsed MDS with del(7q) — Your disease has already recurred after transplant, which means your MDS is aggressive. Jakafi may be helping control this, and stopping it could allow rapid progression.

2. Mixed donor chimerism with CD34 0% donor cells — Your bone marrow is not fully engrafted with donor cells. This means your own (recipient) cells are producing blood, and those cells carry the del(7q) abnormality. Jakafi may be the only thing controlling their proliferation right now.

3. Del(7q) in 96% of cells — This is a high-risk cytogenetic abnormality. Without Jakafi's suppressive effect, these cells could expand rapidly.

In your case, stopping Jakafi abruptly could trigger rapid disease progression.

Why Your Doctor Prescribed a Taper

Your oncologist prescribed every-other-day dosing for a week, then stop for a specific reason: gradual tapering allows your bone marrow to adjust slowly rather than experiencing a sudden shock.

This tapering schedule:

• Gives your body time to re-establish its own regulatory mechanisms
• Reduces the risk of rebound phenomenon
• Allows your doctor to monitor your blood counts during the transition
• Gives you a chance to catch any problems before they become severe

Skipping ahead in the taper defeats this purpose.

What the Medical Literature Says

According to NCCN Guidelines for Myelodysplastic Syndromes and ASCO recommendations for JAK inhibitor use in MDS:

• JAK inhibitors should be discontinued gradually, not abruptly
• Rebound cytopenias or cytosis (dangerous changes in blood counts) are a recognized risk
• Close monitoring during discontinuation is essential
• Patients should not modify their tapering schedule without physician guidance

---

What You Should Do Instead

If You're Having Side Effects

Call your transplant team and tell them specifically:

• What side effects you're experiencing (fatigue, nausea, headache, etc.)
• When they started
• How severe they are
• Whether they're affecting your quality of life

Your doctor may:

• Adjust your dose differently than originally planned
• Add medications to manage side effects
• Switch you to a different medication
• Modify your taper schedule based on your blood counts

If You Just Want to Stop

Tell your doctor directly: "I want to stop Jakafi. Can we discuss this?"

Your oncologist needs to know your wishes and can:

• Discuss why they recommended Jakafi in the first place
• Explain the risks of stopping in your specific situation
• Potentially offer alternatives
• Create a safer discontinuation plan if stopping is appropriate

If You're Concerned About Cost

If cost is the issue, tell your doctor. There are:

• Patient assistance programs for Jakafi
• Generic versions available
• Alternative medications that might be covered differently
• Financial counseling services at your cancer center

---

Questions to Ask Your Transplant Team

1. "Why did you prescribe Jakafi for me, and what is it controlling in my MDS?" — Understanding the purpose helps you make informed decisions.

2. "What happens if I stop Jakafi abruptly vs. following the taper schedule?" — Get specific information about YOUR risk.

3. "Are you seeing improvement in my blood counts or disease markers since starting Jakafi?" — This tells you if it's working.

4. "What side effects should I report immediately, and which ones can I manage at home?" — Know what's urgent vs. manageable.

5. "If I want to stop Jakafi, what's the safest way to do it given my del(7q) relapse?" — Your doctor can create a personalized plan.

6. "How often will you monitor my blood counts during the taper?" — You need to know the monitoring schedule.

---

Bottom Line

Do not skip ahead in your Jakafi taper. Follow the every-other-day schedule your doctor prescribed, then stop after that week. If you want to stop sooner, or if you're having side effects, call your transplant team and discuss it with them first.

Your post-transplant relapsed MDS with del(7q) is a serious situation, and Jakafi may be an important part of controlling your disease right now. Stopping it abruptly could trigger rapid progression.

Your doctor prescribed this taper for your safety — trust the plan, but communicate with your team if something isn't working.

---

Sources

This information is based on:

• NCCN Clinical Practice Guidelines: Myelodysplastic Syndromes
• American Society of Clinical Oncology (ASCO) Guidelines for JAK Inhibitor Use in MDS
• FDA Safety Communications on JAK Inhibitors
• National Cancer Institute (NCI) Information on Jakafi and MDS

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.